PDI抑制α-synuclein纤维化聚集作用机制研究

doi:10.11938/cjmr20170201

波谱学杂志 ›› 2017, Vol. 34 ›› Issue (2): 131-136.doi: 10.11938/cjmr20170201

PDI抑制α-synuclein纤维化聚集作用机制研究

陈艳华^1,2, 张则婷¹, 白佳^1,2, 刘晓黎¹, 刘买利¹, 李从刚¹

1. 中国科学院生物磁共振分析重点实验室, 波谱与原子分子物理国家重点实验室, 武汉磁共振中心(中国科学院武汉物理与数学研究所), 湖北武汉 430071;
2. 中国科学院大学, 北京 100049

收稿日期:2016-04-22 修回日期:2017-04-19 出版日期:2017-06-05 发布日期:2017-06-05
通讯作者: 张则婷,Tel:027-87197391,E-mail:zhangzeting@wipm.ac.cn. E-mail:zhangzeting@wipm.ac.cn
基金资助:
国家自然科学基金资助项目（21203243）.

Inhibition Mechanisms of Protein Disulfide Isomerase on α-Synuclein Fibril Aggregation

CHEN Yan-hua^1,2, ZHANG Ze-ting¹, BAI Jia^1,2, LIU Xiao-li¹, LIU Mai-li¹, LI Cong-gang¹

1. CAS Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan(Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences), Wuhan 430071, China;
2. University of Chinese Academy of Sciences, Beijing 100049, China

Received:2016-04-22 Revised:2017-04-19 Online:2017-06-05 Published:2017-06-05

摘要/Abstract

摘要： 天然无结构蛋白α-synuclein在帕金森症（PD）患者脑部的路易小体中异常聚集，被认为是引起PD的重要原因之一，但是目前关于α-synuclein的聚集机制仍没有定论．蛋白质二硫键异构酶（PDI）是细胞内质网中重要的分子伴侣蛋白，能够阻止内质网中无结构蛋白的聚集．在PD患者的脑细胞内发现PDI过量表达，且酶活性位点半胱氨酸被亚硝基化使其活性受到抑制．体外实验证明，PDI能够抑制α-synuclein的聚集，但其具体的分子机制还不清楚，研究PDI抑制α-synuclein聚集的具体机制可能对于PD治疗有重要意义．该文利用核磁共振（NMR）方法研究了α-synuclein与PDI的相互作用，发现α-synuclein与PDI的结合位点位于α-synuclein的N端；将PDI所有的6个半胱氨酸突变成丝氨酸，得到突变体PDI C-S，发现α-synuclein与PDI C-S的结合位点则位于其C末端；荧光实验结果表明突变体PDI C-S对α-synuclein纤维化聚集的抑制作用减弱，说明PDI抑制α-synuclein的纤维化聚集主要是通过与α-synuclein的N端残基结合来实现的．

关键词: 相互作用, α-synuclein, 蛋白质二硫键异构酶(PDI), 核磁共振(NMR)

Abstract: Abnormal aggregation of α-synuclein, an intrinsically disordered protein in Lewy bodies, is considered a hallmark of Parkinson's disease (PD). The mechanisms underlying abnormal α-synuclein aggregation, however, are yet to be understood. Protein disulfide isomerase (PDI) is an important molecular chaperone in the endoplasmic reticulum, which can prevent disordered protein forming aggregation. PDI is shown to be overexpressed in the brain of PD patients, but with reduced activity due to S-nitrosylation of the cysteine residues in the active site. In vitro experiments have demonstrated that PDI can inhibit the aggregation of α-synuclein with unknown mechanisms. Hence, it may be of importance to study the inhibition mechanisms of PDI on α-synuclein aggregation. In this study, the interaction between α-synuclein and PDI was studied by NMR spectroscopy. It was found that the binding sites between the two are located on the N-terminal of α-synuclein. A variant PDI (PDI C-S) was prepared, in which all six cysteines were mutated to serines. It was found that the binding sites between PDI C-S and α-synuclein are located on the C-terminus of α-synuclein. The results of thioflavin T (ThT) fluorescence experiment showed that the inhibition activity of PDI C-S on α-synuclein aggregation was lower than the wild type, suggesting that wild type PDI may inhibit α-synuclein aggregation through binding to its N-terminal.

Key words: interaction, protein disulfide isomerase (PDI), NMR, α-synuclein

中图分类号:

O482.53

陈艳华, 张则婷, 白佳, 刘晓黎, 刘买利, 李从刚. PDI抑制α-synuclein纤维化聚集作用机制研究[J]. 波谱学杂志, 2017, 34(2): 131-136.

CHEN Yan-hua, ZHANG Ze-ting, BAI Jia, LIU Xiao-li, LIU Mai-li, LI Cong-gang. Inhibition Mechanisms of Protein Disulfide Isomerase on α-Synuclein Fibril Aggregation[J]. Chinese Journal of Magnetic Resonance, 2017, 34(2): 131-136.

参考文献

[1] SPILLANTINI M G, CROWTHER R A, JAKES R, et al. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies[J]. P Natl Acad Sci USA, 1998, 95(11):6469-6473.
[2] KESSLER J C, ROCHET J C, LANSBURY P T. The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation[J]. Biochemistry, 2003, 42(3):672-678.
[3] ELIEZER D, KUTLUAY E, BUSSELL R, et al. Conformational properties of alpha-synuclein in its free and lipid-associated states[J]. J Mol Biol, 2001, 307(4):1061-1073.
[4] UVERSKY V N, FINK A. Amino acid determinants of alpha-synuclein aggregation:putting together pieces of the puzzle[J]. Febs Lett, 2002, 522(1-3):9-13.
[5] ZHANG L, ZHANG C Y, ZHU Y Y, et al. Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons:An immunogold electron microscopic study using a C-terminal specific monoclonal antibody[J]. Brain Res, 2008, 1244:40-52.
[6] SMITH W W, JIANG H B, PEI Z, et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity[J]. Hum Mol Genet, 2005, 14(24):3801-3811.
[7] LYLES M M, GILBERT H F. Catalysis of the oxidative folding of ribonuclease-a by protein disulfide isomerase-dependence of the rate on the composition of the redox buffer[J]. Biochemistry, 1991, 30(3):613-619.
[8] FREEDMAN R B, DUNN A D, RUDDOCK L W. Protein folding:A missing redox link in the endoplasmic reticulum[J]. Curr Biol, 1998, 8(13):468-470.
[9] CAI H, WANG C C, TSOU C L. Chaperone-like activity of protein disulfide-isomerase in the refolding of a protein with no disulfide bonds[J]. J Biol Chem, 1994, 269(40):24550-24552.
[10] MAATTANEN P, GEHRING K, BERGERON J J M, et al. Protein quality control in the ER:The recognition of misfolded proteins[J]. Semin Cell Dev Biol, 2010, 21(5):500-511.
[11] WANG C, LI W, REN J Q, et al. Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase[J]. Antioxid Redox Sign, 2013, 19(1):44-53.
[12] KLAPPA P, RUDDOCK L W, DARBY N J, et al. The b' domain provides the principal peptide-binding site of protein disulfide isomerase but all domains contribute to binding of misfolded proteins[J]. Embo J, 1998, 17(4):927-935.
[13] FREEDMAN R B, GANE P J, HAWKINS H C, et al. Experimental and theoretical analyses of the domain architecture of mammalian protein disulphide-isomerase[J]. Biol Chem, 1998, 379(3):321-328.
[14] UEHARA T, NAKAMURA T, YAO D D, et al. S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration[J]. Nature, 2006, 441(7092):513-517.
[15] NAKAMURA T, TU S C, AKHTAR M W, et al. Aberrant protein S-nitrosylation in neurodegenerative diseases[J]. Neuron, 2013, 78(4):596-614.
[16] CHENG H, WANG L, WANG C C. Domain a' of protein disulfide isomerase plays key role in inhibiting alpha-synuclein fibril formation[J]. Cell Stress Chaperon, 2010, 15(4):415-421.
[17] DAI C Y, ZHANG Z T, LIU M L, et al. Application of NMR in the studies of structure and interactions of α-synuclein[J]. Chinese J Magn Reson, 2016, 33(1):154-167. 戴晨晔, 张则婷, 刘买利, 等. NMR在α-synuclein的结构及相互作用研究中的应用[J]. 波谱学杂志, 2016, 33(1):154-167.
[18] KHURANA R, COLEMAN C, IONESCU-ZANETTI C, et al. Mechanism of thioflavin T binding to amyloid fibrils[J]. J Struct Biol, 2005, 151(3):229-238.
[19] DAI C Y, LIU M L, LI C G. Salt content-dependent conformational changes of α-synuclein studied by ¹⁹F NMR[J]. Chinese J Magn Reson, 2015, 32(1):33-40. 戴晨晔, 刘买利, 李从刚. 低盐和高盐环境下α-synuclein构象的¹⁹F NMR研究[J]. 波谱学杂志, 2015, 32(1):33-40.
[20] RAO J N, DUA V, ULMER T S. Characterization of alpha-synuclein interactions with selected aggregation-inhibiting small molecules[J]. Biochemistry, 2008, 47(16):4651-4656.
[21] XIE Y Y, ZHOU C J, ZHOU Z R, et al. Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein:mechanistic insights and pathological implication[J]. Faseb J, 2010, 24(1):196-205.
[22] ZABROCKI P, BASTIAENS I, DELAY C, et al. Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson[J]. BBA-Mol Cell Res, 2008, 1783(10):1767-1780.
[23] YU J P, MALKOVA S, LYUBCHENKO Y L. Alpha-synuclein misfolding:Single molecule AFM force spectroscopy study[J]. J Mol Biol, 2008, 384(4):992-1001.
[24] HONG D P, XIONG W, CHANG J Y, et al. The role of the C-terminus of human alpha-synuclein:Intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers[J]. Febs Lett, 2011, 585(3):561-566.
[25] LOWE R, POUNTNEY D L, JENSEN P H, et al. Calcium(Ⅱ) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain[J]. Protein Sci, 2004, 13(12):3245-3252.
[26] LI W X, WEST N, COLLA E, et al. Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations[J]. P Natl Acad Sci USA, 2005, 102(6):2162-2167.

PDI抑制α-synuclein纤维化聚集作用机制研究

Inhibition Mechanisms of Protein Disulfide Isomerase on α-Synuclein Fibril Aggregation

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	胡坤, 孙汉董, 普诺·白玛丹增. 量子化学计算核磁共振参数在天然产物结构鉴定中的应用[J]. 波谱学杂志, 2019, 36(3): 359-376.
[2]	尹田鹏, 王雅溶, 王敏, 石文智, 张正茜, 何莎莎. 三个C₁₉-二萜生物碱的NMR数据全归属[J]. 波谱学杂志, 2019, 36(3): 331-340.
[3]	杨云汉, 杜瑶, 应飞祥, 杨俊丽, 夏大真, 夏福婷, 杨丽娟. 柚皮素/β-环糊精超分子体系的包合行为[J]. 波谱学杂志, 2019, 36(3): 319-330.
[4]	王亚兰, 王晓静, 王志伟. 阿齐沙坦的波谱学数据及结构确证[J]. 波谱学杂志, 2019, 36(3): 350-358.
[5]	曹园, 吴永平, 陈东军. 卷柏属Selaginellin类化合物互变异构的波谱学研究[J]. 波谱学杂志, 2019, 36(2): 155-163.
[6]	陈晓瑛, 俞刚金, 毛诗珍, 刘买利, 杜有如. 利用¹H NMR探究混合离子型/非离子型表面活性剂临界胶束浓度降低的实质[J]. 波谱学杂志, 2019, 36(2): 219-224.
[7]	徐小俊, 王申林. ¹⁹F固体核磁共振技术研究膜蛋白相互作用的进展[J]. 波谱学杂志, 2019, 36(2): 238-251.
[8]	寇新慧, 刘乙祥, 刘兴弘, 李从刚, 刘买利, 姜凌. 探测应答调控蛋白PhoB_N^F20D自由态中存在的Pre-Active构象[J]. 波谱学杂志, 2019, 36(2): 164-171.
[9]	尹田鹏, 罗智慧, 蔡乐, 丁中涛. 天然C₁₉-二萜生物碱的研究进展及其核磁共振波谱特征[J]. 波谱学杂志, 2019, 36(1): 113-126.
[10]	冉梦琳, 覃凌云, 唐淳, 董旭. 磷酸化调控泛素单体与Rad23A/Ubiquilin-1中泛素结合域互作的检测[J]. 波谱学杂志, 2019, 36(1): 15-22.
[11]	魏会强, 于江, 毕常芬, 宁洪鑫, 李祎亮, 刘强. N-异丁酰基-3'-O-(1-氟-1,1,3,3-四异丙基-1,3-二硅氧烷-3-基)-2'-苄氧羰基鸟苷的NMR研究[J]. 波谱学杂志, 2019, 36(1): 93-102.
[12]	李英俊, 杨凯栋, 靳焜, 刘季红, 王思远, 张楠. 基于咔唑-靛红双-硫代碳酰腙衍生物的NMR研究[J]. 波谱学杂志, 2019, 36(1): 83-92.
[13]	迟秀娟, 乔晓亚, 刘颖, 刘惠丽, 陈雷, 王际辉, 艾选军. 拟南芥AtGrp7 RRM结构域的纯化及其结构与结合的初步分析(英文)[J]. 波谱学杂志, 2019, 36(1): 1-14.
[14]	尹田鹏, 汪泽, 陈阳, 邵娅婷, 邓亮, 黎唯. 10-吲哚细胞松弛素chaetoglobosin F的NMR解析[J]. 波谱学杂志, 2019, 36(1): 74-82.
[15]	王伟宇, 胡涵, 徐君, 邓风. Pd-Cu双金属催化剂上加氢反应的仲氢诱导超极化研究[J]. 波谱学杂志, 2018, 35(3): 269-279.